Key facts
- This page summarizes Chad Gassert's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Mar 2022, 17:37.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
Additional SEC filing notes
Footnote F1
The shares were acquired in multiple trades at prices ranging from $27.06 to $27.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Footnote F2
The Reporting Person holds voting and dispositive power over the shares held by Chali Properties LLC.
Footnote F3
The shares were acquired in multiple trades at prices ranging from $27.69 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.